Division of Cardiology, Pulmonology and Vascular Medicine
Düsseldorf, North Rhine-Westphalia, 40225, Germany
NCT Number: NCT01639781
Epidemiological studies suggest that certain foods rich in flavanols, including cocoa products, red wine, and tea, are associated with decreased cardiovascular mortality and morbidity. Dietary interventional studies have corroborated this finding and showed that flavanols can acutely and after sustained ingestion improve surrogate markers of cardiovascular risk including endothelial function. Endothelial dysfunction is the key event in the development and progression of cardiovascular disease. Aging is the major non-modifiable cardiovascular risk factor associated with progressive decline in endothelial function, vascular stiffening and increase in blood pressure. We hypothesize that flavanols can counteract age-dependent vascular changes by interacting with key mechanisms, most prominently endothelial function.
Looking for future studies?
Notify Me18 year–80 year
Male
Interventional
Phase 1
Düsseldorf, North Rhine-Westphalia, 40225, Germany
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Flavanol intervention drinks contain (400 mg flavanols) flavanol rich drink 2 x 400 mg 2 times a day over 2 weeks
Calorically, micro- and macronutrient matched control drink free of flavanols flavanol free drink 2 times a day over 2 weeks
Time frame: change in flow mediated dilatation between first treatment at day 0 and after last treatment at day 14
Flow mediated dilatation (FMD)
Time frame: analysis of metabolites between first treatment at day 0 and after last treatment at day 14
Measured by HPLC
Time frame: blood pressure at day 0 and at day 14
automatical measurements
Time frame: 14 days
Measured by SphygmoCor
Time frame: 14 days
Measured by Laserdoppler perfusion imaging (LDPI)
Time frame: 14 days
Measured by SphygmoCor
Time frame: 14 days
Measured by ECG
Time frame: 14 days
Measured by Laser-assisted Optical Rotation Cell Analyzer (LORCA)
Time frame: 14 days
Measured by CLD
Heinrich-Heine University, Duesseldorf
Other
Age-dependent Effects of Flavanol Metabolism and Absorption on Vascular Status After Acute and Chronic Application.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03188705
Arterial Occlusive Diseases, Arteriosclerosis
Lancaster, Pennsylvania, United States
View Trial DetailsNCT05882045
Body Weight, Cardiovascular Diseases
Phoenix, Arizona, United States
View Trial DetailsNCT02439775
Cardiovascular Diseases, Hypertension
Huntsville, Alabama, United States
View Trial DetailsNCT05820295
Arrhythmias, Cardiac, Atrial Fibrillation
New York, United States
View Trial Details